Dow Up 0.08% Nasdaq Down 0.30%

Stemline Therapeutics, Inc. (STML)

-NasdaqCM
12.79 Down 0.74(5.47%) Sep 19, 4:00PM EDT
Prev Close:13.53
Open:13.35
Bid:12.58 x 300
Ask:14.50 x 600
1y Target Est:62.33
Beta:-4.709
Earnings Date:Oct 20 - Oct 24 (Est.)
Day's Range:12.70 - 13.91
52wk Range:10.50 - 47.25
Volume:239,437
Avg Vol (3m):158,614
Market Cap:165.58M
P/E (ttm):N/A
EPS (ttm):-2.31
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for STML

Comparison

Symbol% ChgMkt Cap
STMLDown 5.47%165.58M
OMEDDown 4.67%510.68M
VSTMDown 4.25%238.52M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):820.69
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-2.39
Quarterly EPS Est (Sep-14) :-0.58
Mean Recommendation*:1.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Stemline Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, acquisition, development, and commercialization of proprietary therapeutics for cancer stem cells and bulk tumors in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback